Overview
Thrombotic thrombocytopenic purpura is treated with 1 medication in our database, including ACD-A. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Fresenius Kabi. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Thrombotic thrombocytopenic purpura treatment below.
Also known as:
Clinical phenotype terms— hover any for plain English:
FDA & Trial Timeline
9 eventsFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico — NA
Assistance Publique - Hôpitaux de Paris
University Hospital, Rouen
Takeda — PHASE2
Turkish Hematology Association
The First Affiliated Hospital of Soochow University
Takeda — PHASE3
CABLIVI is indicated for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
2 availableCablivi
CABLIVI is indicated for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.
ACD-A
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program fo
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
1 grantsCommunity
No community posts yet. Be the first to share your experience with Thrombotic thrombocytopenic purpura.
Start the conversation →Latest news about Thrombotic thrombocytopenic purpura
No recent news articles for Thrombotic thrombocytopenic purpura.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Thrombotic thrombocytopenic purpura
What is Thrombotic thrombocytopenic purpura?
Thrombotic thrombocytopenic purpura is treated with 1 medication in our database, including ACD-A. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Fresenius Kabi. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Thrombotic thrombocytopenic purpura treatment below.
Are there clinical trials for Thrombotic thrombocytopenic purpura?
Yes — 8 recruiting clinical trials are currently listed for Thrombotic thrombocytopenic purpura on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Thrombotic thrombocytopenic purpura?
22 specialists and care centers treating Thrombotic thrombocytopenic purpura are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Thrombotic thrombocytopenic purpura?
1 FDA-approved treatment and 1 patient support program are currently tracked on UniteRare for Thrombotic thrombocytopenic purpura. See the treatments and support programs sections for copay assistance, eligibility, and contact details.